25
Participants
Start Date
May 31, 2003
Primary Completion Date
February 29, 2004
Study Completion Date
February 29, 2008
Thalidomide
200mg orally once a day for 14 weeks if that dosage is tolerated well, it will be increased to 400mg for up to 50 weeks.
Rituximab
Given intravenously once weekly for 4 weeks beginning the second week of study treatment. If tolerated well, this may be repeated 8 weeks later.
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute
OTHER
Massachusetts General Hospital
OTHER
Beth Israel Deaconess Medical Center
OTHER
Brigham and Women's Hospital
OTHER
Cape Cod Hospital
OTHER
Steven P. Treon, MD, PhD
OTHER